1. Stamatakos G, Dionysiou D, Lunzer A, Belleman R, Kolokotroni E, Georgiadi E, et al. The technologically integrated oncosimulator: combining multiscale cancer modeling with information technology in the in silico oncology context. IEEE J Biomed Health Inform. 2014;18:840–54.
2. Stamatakos GS, Graf N, Radhakrishnan R. Multiscale cancer modeling and in silico oncology: emerging computational frontiers in basic and translational cancer research. J Bioeng Biomed Sci. 2013;3:E114.
3. Kolokotroni E, Ouzounoglou E, Stanulla M, Dionysiou D, Stamatakos GS. In Silico Oncology: Developing and Clinically Adapting the Acute Lymphoblastic Leukemia (ALL) Oncosimulator by Exploiting Pathway Based Gene Expression Analysis in the Context of the ALL-BFM 2000 Clinical Study. Virtual Physiological Human Conference 2014 (VPH 2014). In Virtual Physiological Human Conference 2014 (VPH 2014). Trondheim, Norway.
4. p-medicine – Grant Agreement no. 270089 Deliverable No. 12.3 Report on the development of the Oncosimulator and the utilization of the biomechanism models. 2013.
http://p-medicine.eu/fileadmin/p-medicine/public_website/downloads/p-medicine_270089_D12-3_Report_on_the_development_of_the_Oncosimulator_and_the_utilization_of_the_biomechanism_models.pdf
. Accessed 2 May 2015.
5. p-medicine – Grant Agreement no. 270089 Deliverable No. 12.4 Report on the clinical adaptation and optimization of the Oncosimulator models. In silico studies. 2014.
http://p-medicine.eu/fileadmin/p-medicine/public_website/downloads/p-medicine_270089_D12-4_Report_on_clinical_adaptation_and_optimization_of_Oncosimulator_models_v4-0.pdf
. Accessed 2 May 2015.